Stockreport

How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story [Yahoo! Finance]

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations
PDF With fair value steady at $5.75 per share, a slightly higher discount rate and essentially unchanged revenue growth outlook reflect a careful balance between confidence [Read more]